5-Amino-3-methyl-1-(3-nitrophenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 5g

Ethyl bromodifluoroacetate, 98.0%, 25g

3-Cyclopropyl-2-methoxypyridine, 97%, 1g

3-Methoxypyridazine>97.0%(GC)(T)1g

Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate, 97%, 10g

3-Methylpyridine-2-carbaldehyde, 95.0%, 5g

Ethyl 4-(trifluoromethoxy)cyclohexane-1-carboxylate, 98%, 1g

4-Amino-3-methyl-5-nitrobenzoic acid, 98%, 2g

2-Chloro-N-methoxy-N-methylisonicotinamide, 98%, 5g

3-Amino-4,5,6,7-tetrahydro-benzo[b]thiophene-2-carboxylic acid methyl ester, 95.0%, 100mg

Tofacitinib metabolite-1, 5mg

5-Bromo-6-fluorobenzo[d][1,3]dioxole, 98%, 2.5g

4-Acetoxybenzoic acid, 98.0%, 500g